We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Noninvasive AI Tool Maps Atrial Cardiomyopathy to Support Ablation Planning

By HospiMedica International staff writers
Posted on 30 Sep 2026

Atrial cardiomyopathy involves electrical and structural abnormalities in atrial tissue, including fibrosis, and is linked to atrial fibrillation. More...

Identifying affected tissue can help clinicians understand the disease and plan procedures such as ablation. Current assessment may require invasive electroanatomical mapping or magnetic resonance imaging. Researchers have now developed an artificial intelligence approach for noninvasive assessment using electrical recordings from the body surface.

TResearchers at the Universitat Politècnica de València developed an artificial intelligence model based on graph neural networks to locate and quantify atrial tissue abnormalities associated with atrial cardiomyopathy. The system analyzes body surface potential maps obtained from electrodes placed across the torso. It evaluates how cardiac electrical signals are distributed spatially and how they change over time to identify patterns linked to the location and extent of affected atrial tissue.

The proof-of-concept study used simulated data and does not imply immediate clinical application. Researchers developed and evaluated the model using 14,400 simulated body surface potential maps generated from different atrial and torso anatomies. The simulations included varying degrees and locations of atrial cardiomyopathy, allowing assessment across diverse anatomical configurations.

In a baseline configuration using 128 electrodes, the model achieved 89% accuracy in locating affected tissue, with a mean sensitivity of 89% and specificity of 90%. It also reached 84% overall accuracy in determining the extent of affected tissue. The system maintained performance when analyzing anatomies not used during training, and its performance remained relatively stable when signal quality decreased.

The study was published in Discover Computing and involved the Institute of Information and Communications Technologies at the Universitat Politècnica de València, Corify Care S.L., and Karlsruhe Institute of Technology. The results also indicated that anatomical diversity in training data was important, as wider variation in atrial and torso models improved classification ability. The next step stated for the work is validation using records from real patients before transfer to treatment-planning applications.

Related Links
Universitat Politècnica de València


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.